A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment

Cancer Chemotherapy and Pharmacology

Volumn 37, Issue 6, 1996, Pages 574-580

  Raaphorst, G P ^a   Doja, S ^a   Davis, L ^a   Stewart, D ^a   Ng, C E ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cisplatin; Hyperthermia; Thermal sensitization

Indexed keywords

CISPLATIN;

ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG SENSITIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; HYPERTHERMIA; OVARY CARCINOMA; PRIORITY JOURNAL; SENSITIZATION; TEMPERATURE;

CARCINOMA; CELL SURVIVAL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLIOMA; HUMANS; HYPERTHERMIA, INDUCED; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029873922     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050431     Document Type: Article

References (29)

1. Boitrel MTD, Pelletier H, Genne P, Petit JM, Le Grimellec C, Canal P, Ardiet C, Bastian G, Chauffert B (1992) Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells. Int J Cancer 50:677
2. Bowden GT, Kasunic M, Dim D (1983) Sequence dependence for the hyperthermic potentiation of cis-diaminedichloroplatinum (II) induced cyctotoxicity and DNA damage (abstract). Proceedings Third North American Hyperthermia Group, p 161
3. Canon JL, Humblet Y, Symann M (1990) Resistance to cisplatin: How to deal with the problem? Eur J Cancer 26:1
4. DaSilva VF, Raaphorst GP, Goyal R, Feeley MM (1987) Drug cytotoxicity at elevated temperature. J Neurosurg 67:83
5. Douple EB, Strohbehn JW, deSieyes DC, Alborough DP, Trembly BS (1982) Therapeutic potentiation of cis-diamminedichloroplatinum(II) and radiation by interstitial microwave hyperthermia in a mouse tumour. Natl Inst Drug Abuse Res Monogr Ser 61:259
6. Eastman A, Schulte N (1988) Enhanced DNA repair as a mechanism of resistance to cis-diaminedichloroplatinum (II). Biochemistry 27:4730
7. Eichholtz-Wirth H, Hietel B (1990) Heat sensitization to cisplatin in two cell lines with different drug sensitivities. Int J Hyperthermia 6:47
8. Engelhardt R (1987) Hyperthermia and drugs. Recent Results Cancer Res 104:136
9. Hahn GM (1979) Potentiation of therapy drugs and hyperthermia. Cancer Res 39:2264
10. Hamilton TC, Lai GM, Rothenberg LM, Fojo AT, Young RC, Ozols RF (1989) Mechanisms of resistance to cisplatin and alkylating agents. In: Ozols RF (ed) Drug resistance in cancer therapy. Kluwer Academic Publishers, Boston page 151-169
11. Herman TS, Sweets CC, White DM, Gerner EW (1982) Effect of rate of heating on lethality due to hyperthermia and selected chemotherapy drugs. J Natl Cancer Inst 68:487
12. Herman TS, Teicher BA, Cathcart FNS, Kaufman ME, Lee JB, Lee M (1988) Effect of hyperthermia on cisdiaminedichloroplatinum (II) and pt(Rh-123) in a human squamous carcinoma cell line and a cisplatin resistant subline. Cancer Res 48:5101
13. Jekunen AP, Hom DK, Alcaraz JE, Eastman A, Howell SB (1994) Cellular pharmacology of dichloro(ethylenediamine) platin II in cisplatin-sensitive and resistant human ovarian carcinoma cells. Cancer Res 54:2680
14. Kimura E, Howell SB (1993) Analysis of the cytotoxic interaction between cisplatin and hyperthermia in human ovarian carcioma cell line. Cancer Chemother Pharmacol 32:419
15. Konings AWT, Hettinga JVE, Lemstra W, Humphrey GB, Kapinga HH (1993) Sensitizing for cisplatin action by hyperthermia in resistant cells. Int J Hyperthermia 9:553
16. 1 or late S phase. Cancer Res 53:1239
17. Kubota N, Kakehi M, Inada T (1993) Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids. Int J Radiat Oncol 25:491
18. Lai GM, Ozols RF, Smyth JF, Young RC, Hamilton TC (1988) Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem Pharmacol 37:4597
19. Mansouri A, Henle KJ, Benson AM, Moss AJ, Nagle WA (1989) Characterization of a cisplatin-resistant subline of murine RIF-1 cells and reversal of drug resistance by hyperthermia. Cancer Res 49:2674
20. Masuda H, Tanaka T, Kido A, Kitamura K, Kusaba I (1991) Hyperthermic enhancement of cytotoxicity and DNA-binding of cisplatin in sensitive and resistant human ovarian cancer cell lines. Cancer J 4:283
21. Meijer C, Mulder NH, Hospers GAP, Uges DRA, de Vries EGE (1990) The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 62:72
22. Micetich K, Zwelling L, Kohn KW (1983) Quenching of DNA:platinum (II) monoadducts as a possible mechanism of resistance to cis-diaminedichloroplatinum (II) in L1210 cells. Cancer Res 43:3609
23. Miyahara T, Ueda K, Akaboshi M, Shimada Y, Imamura M, Utsumi H (1993) Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diaminedichloroplatinum (II) in cultured human esophageal cancer cells. Jpn J Cancer Res 84:336
24. Raaphorst GP, Chabot P, Doja S, Wilkins D, Stewart D, Ng CE (1995) Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment. Int J Hyperthermia (in press)
25. 4 rat glioma in vitro and in vivo. Int J Radial Oncol 23:109
26. Supi G, Badaracco G, Cavatiere R, Natali FG, Gerco C (1994) Influence of sequence on hyperthermia and drug combination. Hyperthermic Oncol 1:429
27. Tashiro T, Sato Y (1992) Characterization of acquired resistance to cis-diaminedichloroplatinum (I) in mouse leukemia cell lines. Jpn J Cancer Res 83:219
28. Urano M, Kahn J, Kenton LA (1990) The effect of cisplatin I treatment at elevated temperatures on murine fibrosarcoma. F.Sa-II. Int J Hyperthermia 6:563
29. Westermark B, Ponten J, Hugossen R (1973) Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand [A] 81:791